Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 2.89 USD -1.03%
Market Cap: 853.6m USD
Have any thoughts about
Abcellera Biologics Inc?
Write Note

Abcellera Biologics Inc
Investor Relations

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. The company is headquartered in Vancouver, British Columbia and currently employs 386 full-time employees. The company went IPO on 2020-12-11. AbCellera's full-stack, artificial intelligence (AI)-powered drug discovery platform integrates technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, enabling them to tackle the toughest problems in drug development.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Dr. Veronique Lecault Ph.D.
COO & Director
No Bio Available
Marcie Thiessen CPA, CGA
Senior Director of Finance & Accounting
No Bio Available
Dr. Ester Falconer Ph.D.
Chief Technology Officer
No Bio Available
Kathleen Reid B.A.
Head of Corporate Communications
No Bio Available
Graham Craig M.Sc.
Director of Corporate Development
No Bio Available
Mr. Murray McCutcheon Ph.D.
Senior Vice President of Partnering
No Bio Available
Mr. Neil Aubuchon B.A., M.B.A.
Chief Commercial Officer
No Bio Available
Mr. Adam Clarke M.A.I.C.D., Ph.D.
Senior Vice President of Discovery
No Bio Available
Mr. Paul Colussi Ph.D.
Site Head & VP of Complex Membrane Protein Technologies
No Bio Available
Janna Bednenko Ph.D.
Head of Protein Expression & Genetics
No Bio Available

Contacts

Address
BRITISH COLUMBIA
Vancouver
2215 Yukon Street
Contacts
+16045599005.0
www.abcellera.com